scispace - formally typeset
Y

Youssef Saklawi

Researcher at Emory University

Publications -  4
Citations -  1460

Youssef Saklawi is an academic researcher from Emory University. The author has contributed to research in topics: Hazard ratio & Systems immunology. The author has an hindex of 3, co-authored 3 publications receiving 579 citations.

Papers
More filters
Journal ArticleDOI

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

Andre C. Kalil, +59 more
TL;DR: Baricitinib plus remdesivir was superior to remdes Vivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation.
Journal ArticleDOI

Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.

TL;DR: This paper has developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays, and could streamline detection and decrease reagent use during current high Sars-CoVs testing demands.
Journal ArticleDOI

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, +235 more
TL;DR: The primary outcome was the difference in mechanical ventilation-free survival by day 29 between the two treatment groups in the modified intention-to-treat population.
Journal ArticleDOI

The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients.

TL;DR: Systems biology approaches are used to improve vaccine efficacy in immunocompromised patients, particularly SOTRs, and may hold key insights to vaccination in this vulnerable population.